Dr. Daniel Nader, D.O

NPI: 1972564169
Total Payments
$47,133
2022 Payments
$525.00
Companies
29
Transactions
100
Medicare Patients
709
Medicare Billing
$54,162

Payment Breakdown by Category

Research$28,272 (60.0%)
Consulting$15,276 (32.4%)
Food & Beverage$1,878 (4.0%)
Travel$1,050 (2.2%)
Other$450.00 (1.0%)
Education$207.11 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $28,272 1 60.0%
Consulting Fee $15,276 19 32.4%
Food and Beverage $1,878 72 4.0%
Travel and Lodging $1,050 5 2.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $450.00 1 1.0%
Education $207.11 2 0.4%

Payments by Type

Research
$28,272
1 transactions
General
$18,861
99 transactions

Top Paying Companies

Company Total Records Latest Year
Becton, Dickinson and Company $28,272 1 $0 (2018)
Spiration, Inc. $10,778 15 $0 (2019)
Covidien LP $3,145 8 $0 (2017)
Gyrus ACMI, Inc. $1,800 3 $0 (2022)
Auris Health, Inc. $1,248 10 $0 (2019)
AstraZeneca Pharmaceuticals LP $463.99 2 $0 (2019)
Novartis Pharmaceuticals Corporation $247.08 13 $0 (2020)
Lilly USA, LLC $205.80 8 $0 (2020)
Ethicon Inc. $202.08 3 $0 (2019)
Genentech USA, Inc. $146.29 4 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2022 $525.00 1 Gyrus ACMI, Inc. ($525.00)
2021 $450.00 1 Gyrus ACMI, Inc. ($450.00)
2020 $883.05 4 Gyrus ACMI, Inc. ($825.00)
2019 $1,625 27 Spiration, Inc. ($750.00)
2018 $35,368 31 Becton, Dickinson and Company ($28,272)
2017 $8,283 36 Spiration, Inc. ($4,628)

All Payment Transactions

100 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
01/26/2022 Gyrus ACMI, Inc. Spiration Valve System (Device) Consulting Fee Cash or cash equivalent $525.00 General
Category: Endotherapy
04/07/2021 Gyrus ACMI, Inc. Spiration Valve System (Device) Consulting Fee Cash or cash equivalent $450.00 General
Category: Endotherapy
09/02/2020 Gyrus ACMI, Inc. SVS (Device) Consulting Fee Cash or cash equivalent $825.00 General
Category: EndoTherapy
02/12/2020 Novartis Pharmaceuticals Corporation PROMACTA (Drug), TASIGNA Food and Beverage In-kind items and services $20.16 General
Category: ONCOLOGY
01/30/2020 Lilly USA, LLC ALIMTA (Drug), CYRAMZA, VERZENIO Food and Beverage In-kind items and services $19.24 General
Category: Oncology
01/22/2020 Bayer HealthCare Pharmaceuticals Inc. Xofigo (Drug), Nubeqa Food and Beverage In-kind items and services $18.65 General
Category: Oncology
12/20/2019 Bayer HealthCare Pharmaceuticals Inc. Xofigo (Drug), Nubeqa Food and Beverage In-kind items and services $18.32 General
Category: Oncology
12/05/2019 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $20.20 General
Category: ONCOLOGY
12/05/2019 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $13.99 General
Category: Oncology
12/02/2019 Genentech USA, Inc. Rituxan (Biological), GAZYVA, VENCLEXTA Food and Beverage In-kind items and services $16.77 General
Category: BioOncology/Immunology
11/20/2019 Seattle Genetics, Inc. Food and Beverage In-kind items and services $14.25 General
10/31/2019 Novartis Pharmaceuticals Corporation PROMACTA (Drug), TASIGNA Food and Beverage In-kind items and services $21.02 General
Category: ONCOLOGY
10/24/2019 Bayer HealthCare Pharmaceuticals Inc. Stivarga (Drug) Food and Beverage In-kind items and services $17.68 General
Category: Oncology
10/01/2019 Genentech USA, Inc. TECENTRIQ (Biological) Education In-kind items and services $99.99 General
Category: BioOncology
08/21/2019 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $22.28 General
Category: ONCOLOGY
07/31/2019 Ethicon Inc. NEUWAVE Flex Microwave Ablation System (Device) Food and Beverage In-kind items and services $20.51 General
Category: Ablation System
07/30/2019 Spiration, Inc. Olympus Respiratory Accessories (Device) Consulting Fee Cash or cash equivalent $450.00 General
Category: GI & Respiratory Products
06/21/2019 Novartis Pharmaceuticals Corporation KISQALI (Drug), PIQRAY Food and Beverage In-kind items and services $15.32 General
Category: ONCOLOGY
06/13/2019 Novartis Pharmaceuticals Corporation PIQRAY (Drug), SANDOSTATIN Food and Beverage In-kind items and services $19.82 General
Category: ONCOLOGY
06/12/2019 Ethicon Inc. MONARCH (Device) Food and Beverage In-kind items and services $86.57 General
Category: ENDO-MECHANICAL
06/12/2019 Novartis Pharmaceuticals Corporation KISQALI (Drug), PIQRAY Food and Beverage In-kind items and services $11.44 General
Category: ONCOLOGY
05/31/2019 Ethicon Inc. MONARCH (Device) Travel and Lodging In-kind items and services $95.00 General
Category: ENDO-MECHANICAL
05/23/2019 Novartis Pharmaceuticals Corporation PROMACTA (Drug), TASIGNA Food and Beverage In-kind items and services $16.20 General
Category: ONCOLOGY
04/29/2019 Janssen Biotech, Inc. Balversa (Drug) Food and Beverage In-kind items and services $18.20 General
Category: Oncology
04/25/2019 Array BioPharma Inc. Braftovi (Drug), Mektovi Food and Beverage In-kind items and services $16.08 General
Category: Melanoma

Research Studies & Clinical Trials

Study Name Company Amount Records
Swift Becton, Dickinson and Company $28,272 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 4 135 151 $57,920 $10,313
2020 13 574 688 $410,482 $43,849
Total Patients
709
Total Services
839
Medicare Billing
$54,162
Procedure Codes
17

All Medicare Procedures & Services

17 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 60 71 $27,477 $4,925 17.9%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 46 50 $12,550 $2,289 18.2%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 17 17 $10,795 $1,804 16.7%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 12 13 $7,098 $1,294 18.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 171 251 $97,137 $14,691 15.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 101 127 $69,342 $10,643 15.3%
99204 New patient office or other outpatient visit, typically 45 minutes Facility 2020 72 72 $45,720 $6,954 15.2%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 23 23 $19,044 $3,034 15.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 55 60 $15,060 $2,251 15.0%
31626 Insertion of radiation therapy markers into lung airways using an endoscope Facility 2020 14 14 $43,260 $1,962 4.5%
31628 Biopsy of one lobe of lung using an endoscope Facility 2020 18 18 $43,794 $1,536 3.5%
31624 Irrigation and suction of lung airways to obtain cells using an endoscope Facility 2020 29 30 $60,390 $934.50 1.5%
99203 New patient office or other outpatient visit, typically 30 minutes Facility 2020 13 13 $4,875 $763.59 15.7%
99202 New patient office or other outpatient visit, typically 20 minutes Facility 2020 12 12 $2,988 $471.30 15.8%
94060 Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration Facility 2020 22 23 $3,082 $233.68 7.6%
94726 Determination of lung volumes using plethysmography Facility 2020 22 22 $3,168 $211.64 6.7%
94729 Measurement of lung diffusing capacity Facility 2020 22 23 $2,622 $163.99 6.3%

About Dr. Daniel Nader, D.O

Dr. Daniel Nader, D.O is a Pulmonary Disease healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972564169.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Nader, D.O has received a total of $47,133 in payments from pharmaceutical and medical device companies, with $525.00 received in 2022. These payments were reported across 100 transactions from 29 companies. The most common payment nature is "" ($28,272).

As a Medicare-enrolled provider, Nader has provided services to 709 Medicare beneficiaries, totaling 839 services with total Medicare billing of $54,162. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.

Practice Information

  • Specialty Pulmonary Disease
  • Location Tulsa, OK
  • Active Since 03/29/2006
  • Last Updated 07/09/2008
  • Taxonomy Code 207RP1001X
  • Entity Type Individual
  • NPI Number 1972564169

Products in Payments

  • Spiration Valve System (Device) $11,003
  • superDimension (Device) $3,113
  • SVS (Device) $825.00
  • Olympus Respiratory Accessories (Device) $750.00
  • Monarch (Device) $280.97
  • MONARCH (Device) $181.57
  • CYRAMZA (Drug) $145.70
  • TECENTRIQ (Biological) $114.53
  • Photofrin (Drug) $111.48
  • MEKINIST (Drug) $62.88
  • ALIMTA (Drug) $60.10
  • PROMACTA (Drug) $57.38
  • Stivarga (Drug) $49.27
  • KISQALI (Drug) $46.74
  • OPDIVO (Biological) $45.62
  • TASIGNA (Drug) $44.72
  • Prolastin-C (Biological) $42.32
  • INJECTAFER (Drug) $41.16
  • Xofigo (Drug) $36.97
  • Aranesp (Biological) $35.35

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pulmonary Disease Doctors in Tulsa